by the purpose of the comparison or the alteration being detected. Because of its breadth, the comparison step covers detection of yet-undiscovered alterations, as well as comparisons for purposes other than detection of cancer. Even with respect to cancer, the comparisons are not limited to the detection of risk of breast or ovarian cancer. Similar concerns to the ones the Supreme Court expressed in Myriad with respect to isolated DNA exist here: allowing a patent on the comparison step could impede a great swath of research relating to the BRCA genes, and it is antithetical to the patent laws to allow these basic building blocks of scientific research to be monopolized. See Myriad, 133 S.Ct. at 2116; see also Gottschalk v. Benson, 409 U.S. 63, 64, 93 S.Ct. 253, 34 L.Ed.2d 273 (1972) (<HOLDING>). The first paragraphs in claims 7 and 8 are
holding that a disclaimer stating  this particular code or policy handbook is not an expressed or implied contract of employment and does not create any contractual rights of any kind between employer and its employees was clear enough that a holding that constitutionally protected property interest in employment does not extend to right to possess and retain particular job or to perform particular services holding that a claim on an algorithm for converting binarycoded decimal numbers into pure binary numbers was not patent eligible because the claims were not limited to any particular art or technology to any particular apparatus or machinery or to any particular end use holding that a written statement could not be regarded as an affidavit sufficient in law for any purpose because it was not sworn to by any one or before any officer holding that courts are not bound to decide any particular jurisdictional question before any other